Comparative Pharmacology of GP IIb/IIIa Antagonists Karsten SchrörArtur-Aron Weber OriginalPaper Pages: 71 - 80
Glycoprotein IIb/IIIa Blockers in Non-ST Elevation Acute Coronary Syndromes: Only for Well Defined Subgroups or a Therapeutic Option for All Patients? Freek W.A. Verheugt OriginalPaper Pages: 81 - 84
Glycoprotein IIb/IIIa Receptor Antagonists in the Treatment of Acute ST Elevation MI: From Hypotheses to Unexpected Recent Observations Allan M. Ross OriginalPaper Pages: 85 - 89
Glycoprotein IIb/IIIa Receptor Inhibitors in Acute ST-Elevation Myocardial Infarction: Will the Combination with Thrombolytics Become Reality? Uwe Zeymer OriginalPaper Pages: 91 - 97
The Role of Glycoprotein IIb/IIIa-Receptor Antagonists in Diabetics Kurt Huber OriginalPaper Pages: 99 - 103
Mesenteric Vein Thrombosis Associated with Intravaginal Contraceptives: A Case Report and Review of the Literature Deepak VooraAnitha Vijayan OriginalPaper Pages: 105 - 108
Local Thrombolytic Therapy in Cancer Patients with Central Venous Catheter Occlusion in Urgent Need of Antiblastic Treatment: A Single Institution Experience Alberto AgazziDaniele LaszloGiovanni Martinelli OriginalPaper Pages: 109 - 111
A Retrospective Evaluation of the Management of Excessive Anticoagulation in an Established Clinical Pharmacy Anticoagulation Service Compared to Traditional Care Daniel M. WittTammy L. Humphries OriginalPaper Pages: 113 - 118
Primary Angioplasty in Acute Myocardial Infarction: Does Age or Race Matter? Carol R. RegueiroNikita GillRichard P. Shannon OriginalPaper Pages: 119 - 123